Your browser doesn't support javascript.
loading
Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus.
Sastry, Mallika; Zhang, Baoshan; Chen, Man; Joyce, M Gordon; Kong, Wing-Pui; Chuang, Gwo-Yu; Ko, Kiyoon; Kumar, Azad; Silacci, Chiara; Thom, Michelle; Salazar, Andres M; Corti, Davide; Lanzavecchia, Antonio; Taylor, Geraldine; Mascola, John R; Graham, Barney S; Kwong, Peter D.
Affiliation
  • Sastry M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Zhang B; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Chen M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Joyce MG; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Kong WP; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Chuang GY; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Ko K; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Kumar A; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Silacci C; Institute for Research in Biomedicine, Bellinzona, Switzerland.
  • Thom M; The Pirbright Institute, Ash Road, Pirbright, Woking, Surrey GU24 0NF, United Kingdom.
  • Salazar AM; Oncovir Inc., Washington, D.C, United States of America.
  • Corti D; Institute for Research in Biomedicine, Bellinzona, Switzerland.
  • Lanzavecchia A; Humabs BioMed SA, Bellinzona, Switzerland.
  • Taylor G; Institute for Research in Biomedicine, Bellinzona, Switzerland.
  • Mascola JR; The Pirbright Institute, Ash Road, Pirbright, Woking, Surrey GU24 0NF, United Kingdom.
  • Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Kwong PD; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
PLoS One ; 12(10): e0186854, 2017.
Article in En | MEDLINE | ID: mdl-29073183
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Syncytial Viruses / Viral Fusion Proteins / Adjuvants, Immunologic / Antibodies, Neutralizing / Antibodies, Viral Limits: Animals Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2017 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Syncytial Viruses / Viral Fusion Proteins / Adjuvants, Immunologic / Antibodies, Neutralizing / Antibodies, Viral Limits: Animals Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2017 Type: Article Affiliation country: United States